One Serum Outperforms Three-Product Regimens in Clinical Study

Dr. Carolyn Jacob, a board-certified dermatologist and founder of Chicago Cosmetic Surgery and Dermatology, oversaw the blinded evaluation. The study enrolled women aged 44 to 71 to compare the single-step serum against a combination of vitamin C, hyaluronic acid, and peptide treatments. By the end of the eight-week trial, the ARS-treated side demonstrated superior results in metrics ranging from radiance and skin roughness to overall appearance, tying only in the assessment of sagging.

The findings point to the efficacy of the company's patented Tiered-Release Vesicle (TRV) technology. This delivery system allows the serum to house bioactive peptides, dual-weight hyaluronic acid, vitamin C, and niacinamide in one formulation, mimicking the payload capacity of multiple products. Beyond clinical grading, participant feedback was unanimous: 100% of subjects found the streamlined approach easier to maintain, and 83% expressed a clear preference for the single-step regimen over the multi-product alternative.